{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:08:29Z","timestamp":1782410909030,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.109884","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T19:38:30Z","timestamp":1590867510000},"page":"109884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Neutralizing antibodies mediate virus-immune pathology of COVID-19"],"prefix":"10.1016","volume":"143","author":[{"given":"J.J.L.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109884_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probably bat origen","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.109884_b0010","unstructured":"Anonymus COVID-19 coronavirus pandemic. Assessed 02-05-2012. https:\/\/www.worldometers.info\/coronavirus\/."},{"key":"10.1016\/j.mehy.2020.109884_b0015","doi-asserted-by":"crossref","unstructured":"C. Huang, Y Wang, X Li et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (10223) (2020), p. 497\u201306. https:\/\/reader.elsevier.com\/reader\/sd\/pii\/S0140673620301835.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"10.1016\/j.mehy.2020.109884_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2020.109884_b0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.2000.0757","article-title":"Coronavirus spike proteins in viral entry and pathogenesis","volume":"279","author":"Gallagher","year":"2001","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.mehy.2020.109884_b0030","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.7150\/ijbs.45123","article-title":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2","volume":"16","author":"Zhou","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.mehy.2020.109884_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2105-15-161","article-title":"A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design","volume":"15","author":"Sharmin","year":"2014","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.mehy.2020.109884_b0040","unstructured":"Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel Coronavirus Disease (COVID-19). Clin Inf Dis. (2020). In press. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7184472\/pdf\/ciaa310.pdf."},{"key":"10.1016\/j.mehy.2020.109884_b0045","doi-asserted-by":"crossref","unstructured":"Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. The novel Coronavirus, 2019-nCoV, is highly contagious and more infectious than initially estimated. MedRXIV. (2020). Preprint. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.02.07.20021154v1.","DOI":"10.1101\/2020.02.07.20021154"},{"key":"10.1016\/j.mehy.2020.109884_b0050","unstructured":"Sungnak W, Huang N, B\u00e9cavin C et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. (2020). In press. https:\/\/www.nature.com\/articles\/s41591-020-0868-6.pdf."},{"key":"10.1016\/j.mehy.2020.109884_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.mehy.2020.109884_b0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.mehy.2020.109884_b0065","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2020.109884_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia","author":"Quinti","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mehy.2020.109884_b0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/v12040360","article-title":"Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins","volume":"12","author":"Srinivasan","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.mehy.2020.109884_b0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.mehy.2020.109884_b0085","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa161","article-title":"Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan","author":"Monto","year":"2020","journal-title":"J Infect Dis."},{"issue":"1","key":"10.1016\/j.mehy.2020.109884_b0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","article-title":"T cell-mediated immune response to respiratory coronaviruses","volume":"59","author":"Channappanavar","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.mehy.2020.109884_b0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.mehy.2020.109884_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25871","article-title":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early","author":"Tan","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.mehy.2020.109884_b0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12948-017-0077-0","article-title":"Immunosenescence in aging: between immune cells depletion and cytokines up-regulation","volume":"15","author":"Ventura","year":"2017","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.mehy.2020.109884_b0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0065-3519(99)80026-3","article-title":"Evaluation of Risks and Benefits Associated with Vaccination against Coronavirus Infections in Cats","volume":"41","author":"Scott","year":"1999","journal-title":"Adv Vet Med"},{"issue":"5","key":"10.1016\/j.mehy.2020.109884_b0115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1139\/cjpp-2014-0352","article-title":"An update on the association of vitamin D deficiency with common infectious diseases","volume":"93","author":"Watkins","year":"2015","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.mehy.2020.109884_b0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fimmu.2018.00458","article-title":"Vitamin D in human immunodeficiency virus infection: influence on immunity and disease","volume":"9","author":"Jim\u00e9nez-Sousa","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2020.109884_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065835","article-title":"Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Bergman","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mehy.2020.109884_b0130","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/nu12040988","article-title":"Evidence that Vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths","volume":"12","author":"Grant","year":"2020","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.mehy.2020.109884_b0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1358\/dot.2006.42.12.1025703","article-title":"Interleukin-2 for the treatment of human immunodeficiency virus infection. Review","volume":"42","author":"Temesgen","year":"2006","journal-title":"Drugs Today"},{"issue":"12","key":"10.1016\/j.mehy.2020.109884_b0140","first-page":"5241","article-title":"Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report","volume":"29","author":"Tomova","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.mehy.2020.109884_b0145","doi-asserted-by":"crossref","unstructured":"Wu F, Wang A, Liu M, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv (2020): 2020.03.30.20047365. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.03.30.20047365v2.","DOI":"10.1101\/2020.03.30.20047365"},{"key":"10.1016\/j.mehy.2020.109884_b0150","unstructured":"Anonymus. \u201cImmunity passports\u201d in the context of COVID-19. Scientific brief.Pubished online 24 April 2020. https:\/\/www.who.int\/news-room\/commentaries\/detail\/immunity-passports-in-the-context-of-covid-19."},{"key":"10.1016\/j.mehy.2020.109884_b0155","first-page":"193","article-title":"SARS Immunity and Vaccination","volume":"1","author":"Zin","year":"2004","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2020.109884_b0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbrc.2005.08.032","article-title":"Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus","volume":"336","author":"Shang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.mehy.2020.109884_b0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.mehy.2020.109884_b0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2009.09.004","article-title":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a","volume":"84","author":"Kohyama","year":"2009","journal-title":"Antiviral Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720311270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720311270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:23:46Z","timestamp":1759692226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720311270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":34,"alternative-id":["S0306987720311270"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109884","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing antibodies mediate virus-immune pathology of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109884"}}